临床再程放疗累积剂量评估:ESTRO再程放疗工作组技术考量共识指南
Reirradiation is increasingly used, but its safe application requires accurate evaluation of cumulative doses to organs at risk.…
要点
- 推荐对再程放疗进行3D累积剂量评估,包括刚性及可变形图像配准的剂量映射。
- 当3D剂量叠加不可行或次优时,应遵循共识提供的替代方案及特殊考量。
- 需关注放射生物学校正(如EQD2Gy和BED)、不确定性评估、文档记录与同行评审。
核心结论
- 该指南为标准化累积剂量评估的技术方面提供了实用框架,以支持临床决策并提高再程放疗的安全性和有效性,同时减少机构间差异。
研究设计与样本
- 由ESTRO再程放疗焦点组认可,写作组(n=15)分析从完整3D剂量叠加到数据不完整及图像配准不可接受等场景,通过结构化专家讨论和两步投票流程制定推荐。
主要发现
- 累积剂量评估方法从简单处方剂量相加到复杂三维剂量叠加方法差异广泛,最佳实践尚未定义。
- 关键讨论点包括剂量映射(刚性及可变形图像配准)、放射生物学校正(如EQD2Gy和BED)、不确定性、文档记录的作用、质量控制和同行评审。
关键数值与推荐
- 指南提供关于3D剂量叠加技术方面的详细推荐,以及不可行、次优或需特殊考虑时的适当替代方案。
- 指南提供关于不确定性评估、资源管理和治疗实施影响的一般指导。
临床怎么用
- 临床再程放疗应准确评估危及器官的累积剂量,优先采用3D剂量叠加方法。
- 当3D剂量叠加不可行或不理想时,可依据共识推荐选择适当替代方案并考虑特殊因素。
- 应整合放射生物学校正、不确定性分析、文档记录、质量控制和同行评审于累积剂量评估流程。
局限性
- 指南强调仍需对先进剂量映射、图像配准及不确定性分析整合开展研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Reirradiation is increasingly used, but its safe application requires accurate evaluation of cumulative doses to organs at risk. Methods of cumulative dose evaluation vary widely, from simple summation of prescription doses to complex three-dimensional (3D) dose summation methodologies, yet best practices remain undefined. This guidance, endorsed by the ESTRO Reirradiation Focus Group, provides detailed recommendations on the technical aspects of 3D dose summation; appropriate alternatives when it is unfeasible, suboptimal, or requires special considerations; and general guidance on uncertainty evaluation, resource management, and implications for treatment delivery. The writing group (n = 15) analysed scenarios ranging from full 3D dose summation to situations with incomplete data and unacceptable image registration, and developed recommendations through structured expert discussion and a two-step voting process. Key discussion points included: dose mapping (with rigid and deformable image registration), radiobiological corrections (particularly equieffective dose rescaling, such as EQD2Gy and BED), uncertainties, role of documentation, quality control, and peer review. Thirty-five statements reached consensus within both the writing group and the full ESTRO Physics Reirradiation Working Group (n = 34, 66 % response rate). Altogether, this guidance offers a practical framework for standardizing the technical aspects of cumulative dose evaluation to support clinical decision making and improve safety and effectiveness of reirradiation, while reducing institutional variability. It also highlights ongoing needs for research into advanced dose mapping, image registration, and integration of uncertainty analyses.
引用
- Appelt AL, Andrzejewski P, Hoffmann L, et al. Cumulative dose evaluation in clinical reirradiation - Consensus guidance on technical considerations by the ESTRO reirradiation focus group. Radiother Oncol. 2025. PMID: 41318002. doi:10.1016/j.radonc.2025.111313
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。